WASHINGTON, DC — Federal investigators have uncovered a troubling pattern of antipsychotic medication misuse in nursing homes nationwide, including facilities deliberately misdiagnosing residents with schizophrenia to conceal inappropriate prescribing practices and inflate quality ratings, according to dual reports released Thursday by the Office of Inspector General.
The investigation revealed that antipsychotic drugs were frequently administered to dementia patients to control behavior without attempting non-drug interventions first, despite Food and Drug Administration warnings about increased death risk, as reported by the OIG. Staff members acknowledged using these medications to manage workloads by sedating residents, according to the federal review.
The OIG based its findings on inspections of 40 nursing homes across the country, assessing compliance with federal requirements for antipsychotic drug use. Investigators documented cases where residents received these powerful medications for non-threatening behaviors such as playing with baby dolls, staying in bed, expressing frustration, or repeatedly requesting assistance, according to the report. In multiple instances, facilities acknowledged the behaviors posed no risk to residents or others but administered the drugs anyway, the review found.
"OIG's comprehensive review of 40 focused nursing home inspections completed by CMS found alarming instances of inappropriate use of antipsychotic drugs and revealed vulnerabilities in care that have implications for the wider nursing home population beyond these examples," the agency stated in its brief.
According to the investigation, some facilities used antipsychotic medications as chemical restraints, sedating residents for staff convenience rather than treating medical symptoms, which violates Medicare regulations. Medical directors failed to prevent inappropriate use, and pharmacists did not flag concerns or recommend dosage reductions, the federal watchdog reported.
Facilities frequently failed to monitor residents for serious side effects including elevated blood pressure and dangerous drug interactions, sometimes disregarding physician orders, according to the OIG findings. The lack of proper monitoring created additional risks for vulnerable residents already facing complications from unnecessary medication use.
Deliberate Efforts to Conceal Violations
The second OIG brief exposed systematic efforts by nursing homes to mask inappropriate antipsychotic use through fraudulent schizophrenia diagnoses. Under current Centers for Medicare and Medicaid Services quality measures, residents receiving antipsychotic drugs with a schizophrenia diagnosis are excluded from calculations affecting a facility's publicly reported star rating on Medicare's Care Compare website.
According to the investigation, facilities developed specific protocols ensuring residents prescribed antipsychotic medications received accompanying schizophrenia diagnoses. Staff described electronic health record alerts identifying residents taking antipsychotic drugs without a schizophrenia diagnosis, which prompted nurses to add the diagnosis, the report stated. In other cases, staff printed lists of resident names and directed clinicians to add schizophrenia diagnoses to medical records, according to investigators.
"Nursing homes inappropriately diagnosed residents with schizophrenia to mask the nursing homes' misuse of antipsychotic drugs and to artificially inflate their star ratings," the OIG stated.
These false diagnoses resulted in residents receiving inadequate evaluations and inappropriate treatment, according to the review. Dementia patients were treated incorrectly, missing opportunities for appropriate non-drug interventions that could have addressed their actual care needs, the investigation found.
Industry Response and Systemic Concerns
Jodi Eyigor, vice president of health policy at LeadingAge, an association representing nonprofit aging services providers, condemned the practices documented in the federal review.
"Antipsychotics should never be used as chemical restraints and false diagnoses should never be applied to justify inappropriate use of a medication," Eyigor said. "These issues should be identified and promptly corrected at the individual level and addressed at the systems level to prevent future occurrences of such practices. But the work cannot stop there."
The OIG characterized the examples of misuse as representing broader vulnerabilities affecting the nursing home population beyond the specific facilities reviewed. Federal regulations require nursing homes to attempt non-pharmacological interventions before using antipsychotic medications for behavioral symptoms in dementia patients.
The FDA has issued black box warnings about antipsychotic drugs increasing the risk of death in elderly patients with dementia-related psychosis. Despite these warnings, the investigation found facilities routinely bypassed safety protocols designed to protect vulnerable residents.
The federal watchdog recommended that CMS strengthen oversight efforts to prevent inappropriate antipsychotic drug use in nursing homes, though specific enforcement measures were not detailed in the publicly released portions of the reports.
Resources for Families
Families concerned about medication practices in nursing homes can contact the National Long-Term Care Ombudsman Resource Center at 1-800-677-1116. The ombudsman program provides free, confidential assistance to residents and families addressing concerns about care quality.
Additional information about nursing home quality ratings and inspection reports is available through Medicare's Care Compare website at medicare.gov/care-compare. Families should review inspection histories and quality measures when evaluating facilities.
Suspected violations of federal nursing home regulations can be reported to state survey agencies or CMS through official complaint channels. Documentation of concerning medication practices, including unexplained behavior changes or excessive sedation, can support regulatory investigations.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.